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Neste trabalho, o método de precipitação de proteínas e cromatografia líquida de alta 
eficiência com detecção de fluorescência (PP/CLAE-fluorescência) foi desenvolvido para a 
análise enantioseletiva da fluoxetina e norfluoxetina em amostras de plasmas. Diferentes agentes 
precipitantes, como solventes orgânicos, ácidos e sais, em diferentes proporções, foram avaliados. 
Segundo testes calorimétricos de Bradford, dentre todos os agentes precipitantes avaliados, 
a acetonitrila apresentou maior eficiência, considerando o número de etapas requeridas e a 
porcentagem de precipitação de proteínas (99,7%), quando adicionado na proporção de 3:1 (agente 
precipitante: plasma, v/v). O método PP/CLAE-fluorescência apresentou limite de quantificação de 
30 ng mL−1 e intervalo linear de 30 a 1000 ng mL−1 com coeficientes de regressão linear acima de 
0,9973 para os quatro enantiômeros. Em conclusão, o método PP/CLAE-fluorescência padronizado 
e validado proposto neste estudo foi aplicado com sucesso na análise de amostras de plasma de 
pacientes em terapia com a fluoxetina.
In this study, the enantioselective analysis of fluoxetine and norfluoxetine in plasma samples 
was performed by the protein precipitation method and high performance liquid chromatography 
with fluorescence detection (PP/LC-FD). Different precipitating agents - organic solvents, acids, 
and salts - in several proportions were available. The Bradford colorimetric method employed for 
evaluation of the efficiency of protein precipitation, has shown that for the sake of simplicity and 
percentage of protein precipitation (99.7%), acetonitrile was most effective when added at a ratio 
of 3:1 (acetonitrile/plasma, v/v). The quantification limit of the PP/LC-FD method was 30 ng mL−1 
for the four enantiomers. The response of the proposed method was linear over a dynamic range 
from LOQ to 1000 ng mL−1, with correlation coefficients higher than 0.9973. In conclusion, the 
PP/LC-FD method can be successfully used to analyze plasma samples from ageing patients 
undergoing therapy with fluoxetine.
Keywords: fluoxetine and norfluoxetine, enantioselective analysis, protein precipitation, 
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Introduction
Fluoxetine (FLX) (N-methyl-3-phenyl-3-[(α,α,α-
trifluoro-p-tolyl)oxy]-propylamine) is one of the most 
widely prescribed selective serotonin reuptake inhibitors for 
the treatment of depression. Factors affecting the safety and 
efficacy of the drug have not been fully characterized, although 
fluoxetine have been available for over 20 years. The lack of a 
suitable test to discriminate between the R and S enantiomers 
of fluoxetine and its active demethylated metabolite, 
norfluoxetine (NFLX), has hampered assessments of the 
potential correlation between clinical response and plasma 
levels of fluoxetine and / or norfluoxetine for many years.1 
The chemical structures of the enantiomers of fluoxetine and 
norfluoxetine are shown in Figure 1.
In fact, while the two FLX enantiomers are approximately 
equipotent in blocking 5-HT (serotonin) reuptake, 
the NFLX enantiomers display marked differences in 
pharmacological activity, with the S-enantiomer being 
approximately 20 times more potent than the R-enantiomer 
as a 5-HT-reuptake inhibitor both in vitro and in vivo.2,3 On 
the basis of these results, it is evident that the concentration 
of individual enantiomers should be taken into account 
for a proper understanding of the role of pharmacokinetic 
variability in the explanation of intraindividual and 
interindividual clinical response.
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For this purpose, several chromatographic methods 
(both gas chromatography, GC, and liquid chromatography, 
LC) have been described for the determination of FLX and 
NFLX enantiomers, including direct (using chiral stationary 
phases) and indirect (after derivatization in mobile 
phase) methods.4-8 Moreover, as fast and reliable high 
throughput analysis of drug and metabolite concentrations 
in plasma samples is essential for pharmacokinetic, 
pharmacodynamic, and toxicokinetic studies, the protein 
precipitation method (PP) has been an ideal sample 
preparation technique of complex matrices, such as 
plasma, serum, and whole blood, for drug analysis.9,11 In 
protein precipitation, acids, salts, or water miscible organic 
solvents are used to remove the protein by denaturation and 
precipitation. Acids, such as trichloroacetic acid (TCA) 
and perchloric acid, are very efficient at precipitating 
proteins. Organic solvents, such as methanol and ethanol, 
have been widely employed in bioanalysis because of their 
compatibility with LC mobile phases.12 
In order to quantify drug in a plasma sample, it is often 
necessary to disrupt the protein-drug binding, so that the total 
amount of drug can be extracted for analysis. Precipitation 
is useful because it can be utilized to denature the protein, 
destroying its drug binding ability depending on the binding 
mechanism.13 Besides being a very simple and fast procedure, 
the protein precipitation technique can be employed as a 
precursor to other methods and also to increase method 
precision and decrease the consumable costs, as many fully 
automated methods employing robotic sample processor in 
the 96-well plate format have been reported.14,15 
This study has evaluated several protein precipitants 
(organic solvents, acids, and salts) in human plasma samples 
by spectrophotometrically examining their effectiveness at 
protein removal, for a high throughput sample analysis of 
fluoxetine, norfluoxetine, and their enantiomers by liquid 
chromatography - fluorescence detection (LC-FD).
Experimental
Reagents and analytical standards
Fluoxetine and norfluoxetine analytical standards 
were donated by Sigma-Aldrich® (São Paulo, Brazil). The 
working standard drug solutions, based on therapeutic 
interval concentrations, were prepared by diluting the stock 
solutions of these drugs (1mg mL−1) to a proper methanol 
volume. These solutions were stable for 18 months at 
− 20 ºC when stored in methanol. The water used to prepare 
the mobile phase had been purified by a Milli-Q system 
(Millipore®, São Paulo, Brazil).
Methanol, acetone and acetonitrile (HPLC grade), 
ethanol, hydrochloric acid, acetic acid, phosphoric acid, 
perchloric acid 70%, trichloroacetic acid, and concentrated 
sulfuric acid were purchased from J.T. Baker® (Phillipsburg, 
USA); potassium hexafluorophosphate 98%, bovine serum 
albumin (BSA), and sodium perchlorate 98% were obtained 
from Aldrich® (Steinheim, Germany). Sodium phosphate 
dibasic, sodium borate, sodium hydroxide, copper sulfate, 
ammonium acetate, zinc sulfate, ammonium sulfate, 
anhydrous sodium sulfate, sodium acetate, and Coomasssie 
Blue G-250 dye were acquired from Merck® (Darmstadt, 
Germany). The saturated aqueous salt solutions were 
prepared at 25 ºC for the PP technique.
Plasma samples
Plasma from healthy volunteers that had not been 
subjected to any pharmacological treatment for at least 
Figure 1. Chemical structures of the enantiomers of fluoxetine and norfluoxetine.
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72 h (blank plasma) was supplied by Hospital das Clínicas 
de Ribeirão Preto, University of São Paulo, Brazil. The 
plasma samples were stored at − 20 ºC for up to 6 months. 
The principles embodied in the Helsinki Declaration 
were observed, and the study was approved by the Ethics 
Committee of the University of São Paulo in Ribeirão Preto, 
Brazil. The plasma sample was collected from elderly 
patients subjected to therapy with fluoxetine for at least 2 
weeks. Blood samples were drawn 12 h after the last drug 
administration.
Instrumentation and chromatographic conditions
The LC-FD analyses were performed in a Shimadzu® 
LC-20AT chromatogaph (Kyoto, Japan) equipped 
with a RF-10AxL detector, and a CBM-20A system 
controller. The enantiomers were separated in the tris-(3,5-
dimethylphenyl carbamate) cellulose column (Chiralcel 
OD-R, 250 × 4.6 mm, 10 mm - Chiralcel Tech®) at room 
temperature (25 ºC) with a mobile phase consisting 
of potassium hexafluorophosphate 7.5 mmol L-1 and 
sodium phosphate 0.25 mol L-1 solution, pH 3.0, and 
acetonitrile (75:25, v/v), in the isocratic mode, at a flow 
rate of 1.0 mL min−1. The column effluent was monitored at 
Ex/Em 230/290 nm. The pH of the mobile phase, adjusted 
with chloridric acid 0.1 mol L-1, was measured in the 
aqueous component alone, and was filtered and degassed 
prior to use. 
A Thermo Spectronic® spectrophotometer (model 
4001/4, USA) was used for the spectrophotometric assays 
at 595 nm. Other instrumentations included a centrifuge 
model 206 BL from Fanem® (São Paulo, Brazil) and a 
tube shaker model MA138 (Marconi®, São Paulo, Brazil).
Protein precipitation procedure
The following protein precipitant solutions were 
prepared: aqueous ammonium, sodium, copper and 
zinc sulfates (saturated at room temperature), aqueous 
ammonium acetate (saturated at room temperature), 
aqueous trichloroacetic acid (TCA) (10%, m/v), aqueous 
perchloric acid 70%, and aqueous sulfuric acid 97%. 
Acetonitrile, ethanol, acetone, and methanol were also 
used as solvent for protein precipitation. Each precipitant 
was added to the plasma samples at volume ratios ranging 
from 0.5:1 to 4:1 (precipitant/plasma, v/v), in triplicate. 
Solutions were shaken for 15 min and centrifuged for 
25 min at 3500 rpm. The plasma sample volume was 
fixed at 100 µL, according to previous studies.12 After the 
precipitation process, the supernatant was collected and 
injected into the LC-FD system. In the cases of protein 
precipitation using acid solutions, the supernatant pH was 
adjusted to 7.0 before the injection.
Protein concentration determination
The Bradford reagent was prepared according to 
the protocol described in the literature.16 Although the 
absorbance of Coomassie Blue dye at 595 nm is proportional 
to the amount of bound protein, it is necessary to establish 
a correspondence between absorbance values and known 
amounts of protein. For this purpose, a series of six BSA 
protein standards was prepared using sequential dilution of 
a protein solution of known concentration in water, from 0 to 
10.0 µg L−1. A volume of 10 µL of the protein precipitant 
was added to 90 µL of each standard solution (0, 2, 4, 6, 8 
and 10 µg L−1). Finally, the volume was completed with 
1 mL of the Bradford reagent. These solutions were shaken 
for 10 s, left to stand for 2 min, and the absorbance was read 
on a spectrophotometer at 595 nm. Once the absorbance for 
all the standards had been measured, a standard curve was 
plotted (absorbance versus known protein content of each 
standard) for each protein precipitant. After registration 
of the absorbance of the unknown sample, the standard 
curves were used for determination of the amount of 
protein corresponding to the measured absorbance values. 
Plasma protein concentration was found by comparing 
absorbance values of the analytical curve and that of the 
plasma sample precipitation and further comparison with 
that of non-precipitated plasma (total), where precipitation 
efficiency = [(total plasma protein − protein remaining in 
the supernatant) / total plasma protein] ×100.
Analytical validation
The analytical validation of the PP/LC-FD method 
was carried out with blank plasma samples spiked with 
drugs standard solutions at concentrations that included 
the therapeutic plasma levels. The linearity was evaluated 
by calibration curves constructed using linear regression 
of the drug peak area (Y) versus the drug nominal 
plasma concentration (X, ng mL−1). These sample 
concentrations ranged from the limit of quantification (LOQ) 
to 1000 ng mL−1.
Accuracy, recovery, and inter-day precision values were 
determined by calibration curves, by means of quintuplicate 
PP/LC-FD assays of the blank plasma samples spiked 
with analytes at concentrations of 100, 300, 400, 500 
and 1000 ng mL−1. Accuracy values were calculated by 
comparison between the drugs concentrations added to 
the plasma samples with plasma drug concentrations 
determined by the calibration curve. Furthermore, 
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the selectivity of the method was also investigated by 
comparison of retention times among the analytes, other 
drugs, and endogenous compounds.
Results and Discussion
Optimization of protein precipitation
The Bradford assay is based on the use of a dye, 
Coomassie Blue G-250, to which protein binds, thus altering 
the light absorbance properties of the dye. When the dye is 
prepared as an acidic solution (in 85% phosphoric acid), 
it maximally absorbs light with a wavelength of 465 nm. 
Protein addition results in a shift of the dye’s absorption 
maximum to 595 nm. As the protein concentration 
increases, the absorbance of light at 595 nm rises linearly, 
and can be measured in a spectrophotometer.16 The BSA 
standard curves at 595 nm for the 12 available precipitants 
were found to be linear, with correlation coefficients higher 
than 0.9938 (Table 1). 
The different protein precipitation techniques lead to 
different modes of protein precipitation.17 Protein solubility 
results from polar interactions with the aqueous solvent, 
ionic interactions with salts, and repulsive electrostatic 
forces between charged molecules. At the isoelectric point 
(pI), there is no net charge on a protein, so similarly the 
protein has minimum solubility in aqueous solvent. Above 
the pI, a protein has a net negative charge, while below its 
pI, it has a net positive charge. Precipitant effectiveness 
increases with volume to a maximum that is reached at 
a ratio of approximately 3 or 4 to 1. The selected volume 
ratios are listed in Table 2.
Results from protein precipitation (percentage of 
precipitation and remaining protein plasma concentration) 
for the twelve precipitants in human plasma are shown 
in Table 2. Each protein precipitation efficiency value 
is an average of three replicates. With the exception of 
ammonium sulfate and sulfuric acid 97%, all precipitants 
were on average at least 90% effective.
Precipitants exert specific effects on proteins in order 
to facilitate their precipitation from solution. Organic 
solvent precipitants lower the dielectric constant of the 
plasma protein solution, which increases the attraction 
between charged molecules and facilitates electrostatic 
protein interactions. The organic solvent also displaces the 
ordered water molecules around the hydrophobic regions 
on the protein surface. Hydrophobic interactions between 
proteins are minimized as a result of the surrounding 
organic solvent, while electrostatic interactions become 
predominant and lead to protein aggregation. Organic 
solvents are the most widely employed protein precipitants 
in drug analysis, especially acetonitrile.9,15 In this work, 
acetonitrile was also found to be the best organic plasma 
protein precipitant, particularly at a 3:1 (precipitant/plasma) 
volume ratio. After precipitation with acetonitrile, and 
other organic solvents, the supernatant was easily dried, 
providing increased analytes concentration just before 
injection into the LC-FD system. 
Acidic reagents form insoluble salts with the positively 
charged amino groups of the protein molecules at pHs 
below their pI. Proteins are precipitated from solutions with 
high salt concentrations as the salt ions become hydrated 
and the number of available water molecules decrease, 
drawing the water away from the protein hydrophobic 
surface regions. This results in aggregation of protein 
molecules via protein-protein hydrophobic interactions.17,18 
This study has also shown that protein precipitation using 
strong acids (perchloric acid 70% and trichloroacetic acid) 
Table 1. Equations and linear coefficients of the calibration curves
Precipitant Linear regression equation Linear correlation coefficient (r 2)
Acids Sulfuric acid 97% Y = 0.05166 * X 0.99783
Perchloric acid 70% Y = 0.03424 * X 0.99499
Trichloroacetic acid 10% Y = 0.03491 * X 0.99387
Salts (satured solution) Ammonium acetate Y = 0.05174 * X 0.99544
Ammonium sulfate Y = 0.04364 * X 0.99962
Sodium sulfate Y = 0.04590 * X 0.99402
Copper sulfate Y = 0.04341 * X 0.99842
Zinc sulfate Y = 0.04389 * X 0.99768
Organic solvents Acetonitrile Y = 0.04625 * X 0.99924
Methanol Y = 0.04635 * X 0.99619
Acetone Y = 0.04715 * X 0.99513
Ethanol Y = 0.03335 * X 0.99581
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is effective at high volume ratios (4:1, Table 2), though there 
is need for an additional step in the process: dilution with 
basic solutions for control of pH after protein precipitation 
and before injection into the LC-FD system. Although 
salt solutions provided efficient protein precipitation by 
the salting-out effect, the high water volume added to the 
plasma sample decreased the analytes concentration in the 
free protein sample.
This study is in general agreement with previously 
reported data using the Lowry method for assessment of 
protein precipitation effectiveness.12 Among the tested 
precipitants, acetonitrile and trichloroacetic acid provided 
the most efficient precipitation compared to precipitants 
with similar mechanisms. Thus, because of the high protein 
precipitation efficiency and simplicity, acetonitrile was 
selected as precipitant at a volume ratio 3:1 (acetonitrile/
plasma) for analytical validation. 
Chromatographic conditions
Due to the high solubility of FLX and its metabolite 
NFLX in water, separation was carried out by reversed 
phase chromatography. For the mobile phase, a mixture of 
two different salt solutions (potassium hexafluorophosphate 
and sodium phosphate) was necessary, to increase 
resolution while at the same time decreasing peak width, 
whereas acetonitrile provided shorter analysis time. 
The most suitable percentage of acetonitrile for a good 
separation in a reasonable analysis time was 25%.
The acid-base properties of FLX and NFLX mean 
that the pH of the mobile phase could influence the 
chromatographic separation. The studied pH range was 
3 to 7, and no significant differences were observed with 
regard to the chromatographic resolution. However, as 
the maximum excitation and emission may vary with pH, 
the influence of this variable on the intensity of the signal 
was studied. A progressive reduction could be observed 
from pH 3, so this was the value selected as optimum for 
the study. 
The identification of R and S enantiomers of fluoxetine 
and norfluoxetine was performed according to literature 
results, considering the elution order of these drugs in the 
same chiral column and detection system.1 The mobile 
phase consisted of potassium hexafluorophosphate 
7.5 mmol L-1 and sodium phosphate 0.25 mol L-1 solution, 
pH 3, acetonitrile (75:25, v/v), at a flow rate of 1.0 mL min−1 
in the isocratic mode. Under this set conditions, the LC-FD 
analysis in the selected mobile phase furnished appropriate 
resolution and satisfactory analysis time (23 min). In 
passing through the stationary phase, Chiralcel OD-R, 
the drug can interact with groups C=O and NH groups 
through hydrogen bonds, in addition to the dipole-dipole 
interactions with the groups C=O,19 which affords good 
resolution ability.
Analytical validation
The validation of PP/LC-FD method was conducted to 
minimize errors, ensure the highest quality of analytical 
work and, consequently, to obtain reliable laboratory results. 
The specificity (selectivity) of the method is demonstrated 
by the following chromatograms: reference plasma blank 
(Figure 2a) and reference plasma sample spiked with the 
enantiomers at a concentration of 500 ng mL−1 (Figure 2b).
 No interfering peaks were found in chromatograms 
obtained after extraction of different sets of blank plasma 
Table 2. Efficiency of proteins precipitation with different agents
Precipitant Proportion 
(precipitant: 
plasma, v/v)
Mean 
absorbance / 
AU
Corresponding 
concentration / 
(g L−1)
Efficiency of protein 
precipitation / 
(%)
Acids Sulfuric acid 97% 1 drop 0.413 7.995 85.7
Perchloric acid 70% 4:1 0.011 0.032 99.9
Trichloroacetic acid 10% 4:1 0.014 0.040 99.9
Salts (satured solution) Ammonium acetate 3:1 0.113 4.368 92.2
Ammonium sulfate 2:1 0.182 8.340 85.1
Sodium sulfate 3:1 0.097 4.226 92.5
Copper sulfate 3:1 0.093 4.284 92.4
Zinc sulfate 4:1 0.084 3.828 93.2
Organic solvents Acetonitrile 3:1 0.071 0.154 99.7
Methanol 4:1 0.336 0.725 98.7
Acetone 2:1 0.171 0.363 99.4
Ethanol 4:1 0.156 0.936 98.3
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samples (n = 5) from drug-free healthy volunteers. This 
gives evidence of the ability of the method to unequivocally 
measure the drugs in the presence of endogenous plasma 
components. Because fluoxetine can be prescribed in 
combination with different psychotropic agents and/or other 
drugs, it is important to evaluate their co-elutions with the 
studied enantiomers. According to Table 3, these drugs did 
not co-elute with the enantiomers under study.
Fluoxetine and norfluoxetine provided a satisfactory 
response in the fluorescence detector. Under our LC-
FD conditions, the limit of detection (LOD – S/N = 3) 
was 5 ng mL−1. This determination was performed with 
standard drugs solutions. The limit of quantification 
(LOQ – S/N = 10) of the enantiomers in plasma was 
30 ng mL−1, with RSD (relative standard deviation) lower 
than 15%, for the four analytes studied here (Table 4). 
The linearity of the method PP / LC-FD was determined 
in plasma samples spiked with reference antidepressants in 
plasma related to the LQ, 300, 400, 500, and 1000 ng mL−1. 
This range was linear, with linear regression coefficients 
above 0.9973, and the coefficients of variation for all 
calibration points were lower than 14% (Table 5).
Figure 2. PP/LC-FD chromatograms. A) Blank plasma sample, B) Blank 
plasma sample spiked with FLX and NFLX, resulting in 500 ng mL−1. 
1: S-Norfluoxetine, 2: R-Norfluoxetine, 3: S-Fluoxetine, 4: R-Fluoxetine.
Table 3. Retention time of the drugs studied as possible interferent
Drugs Retention time / min
4-Methyl primidone 9.343
Amitriptyline nd
Amphetamine nd
Caffeine nd
Carbamazepine nd
Cocaine 7.496
Citalopram (enantiomers) 9.460 / 11.038
Clomipramine Nd
Desipramine Nd
Diazepam 5.721
Phenyl hydantoin nd
Phenytoin nd
Phenobarbital 8.906
Imipramine nd
Methamphetamine nd
Mirtazapine nd
Moclobemide nd
Nortriptyline nd
Paroxetine nd
PEMA 4.894
Primidone 6.603
R-Fluoxetine 22.988
R-Norfluoxetine 17.903
Sertraline nd
S-Fluoxetine 18.883
S-Norfluoxetine 15.664
THC nd
*nd = not detected until 30 min of running. The drugs marked in bold 
are the target analytes.
Table 4. Linearity and coefficient of variation (CV) for the LOQ
Drug Linear regression r² CV / (%), n = 5 (LOQ = 30 ng mL−1)
S-NFLX y = − 27564.22 + 1083.77 x 0.9993 13.6
R-NFLX y = − 32043.92 + 1048.36 x 0.9978 12.5
S-FLX y = − 88237.23 + 1491.19 x 0.9973 9.8
R-FLX y = − 2219.33 + 1484.45 x 0.9976 14.1
The method presented adequate accuracy, with 
values ranging between 91.8% and 117.8%. The inter-
assay precision (n = 5) of the standardized method was 
determined using plasma samples enriched with the 
enantiomer concentrations of 100, 300, 400, 500 and 
1000 ng mL−1. The coefficients of variation at the five 
analyzed concentrations were lower than 14% for the four 
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studied enantiomers (Table 5). These results demonstrate 
that the developed method allows for the quantification 
of antidepressants in the therapeutic interval, although no 
therapeutic levels have been clearly defined for selective 
serotonin reuptake inhibitors.20
The stability of standard solutions of FLX and NFLX, 
as well as plasma samples, had been confirmed in previous 
studies.21,22 According to Kovacevic et al.,21 no significant 
loss is observed for analysis of plasma samples stored in 
methanol for 18 months at − 20 ºC or after a freeze/thaw 
9-month cycle after they were analyzed for the first time. 
These results are proof of the stability of the plasma samples 
and standard solutions in conditions proposed in this work.
To evaluate the applicability of the standardized and 
validated method, plasma samples from elderly patients 
subjected to therapy with fluoxetine (Prozac®, 20 mg per day) 
were analyzed (Figure 3). The detected concentrations 
were 570 ng mL−1 for S-NFLX, 434 ng mL−1 for R-NFLX, 
759 ng mL−1 for S-FLX, and 58 ng mL−1 for R-FLX. 
The PP/LC-FD method developed here give values 
of accuracy and linearity close to those achieved with 
sample preparation methods previously described in the 
literature, such as liquid-liquid extraction (LLE/LC-UV),1 
solid phase extraction (SPE/LC -FD),4 and LLE/GC-NPSD 
(nitrogen-phosphorus selective detector),23 for analysis of 
these enantiomers in biological matrices.
Conclusions
The protein precipitation technique has been shown 
to be a simple and rapid preparation route of plasma 
samples for enantioselective analysis of the antidepressant 
Table 5. Recovery, inter-assay accuracy, and precision of the method PP / LC-FD
Drug [C] / (ng mL−1) Inter-assay (n = 5)
Measured concentration ± σ / 
(ng mL−1)
CV / 
(%)
Accuracy / 
(%)
Absolute recovery / (%)
S-NFLX 100 106.1 ± 12.6 11.8 106.1 54.91
300 304.5 ± 34.3 11.3 101.5 69.22
400 394.5 ± 43.1 10.9 98.6 70.93
500 489.2 ± 45.3 9.3 97.8 61.51
1000 1005.6 ± 103.1 10.3 100.6 71.70
R-NFLX 100 116.7 ± 13.5 11.6 1116.7 68.91
300 286.6 ± 22.8 8.0 95.5 76.48
400 385.0 ± 43.1 11.2 96.3 66.58
500 506.6 ± 49.1 9.7 101.3 65.50
1000 1005.0 ± 135.8 13.5 100.5 73.18
S-FLX 100 117.8 ± 5.3 4.5 117.8 52.46
300 283.0 ± 37.7 13.3 94.3 56.64
400 385.3 ± 27.8 7.2 96.3 60.70
500 509.4 ± 66.6 13.1 101.9 68.11
1000 1004.5 ± 54.5 5.4 100.4 74.29
R-FLX 100 91.8 ± 10.1 11.0 91.8 80.02
300 286.4 ± 30.2 10.5 95.5 81.11
400 415.3 ± 56.8 13.7 103.8 72.35
500 515.5 ± 63.1 12.2 103.1 79.56
1000 991.0 ± 100.4 10.1 99.1 78.83
Figure 3. Chromatogram obtained after protein precipitation from plasma 
samples collected from elderly patient in therapy with fluoxetine in the 
selected mobile phase. The concentrations found in the patient sample 
were 570 ng mL−1 for S-NFLX, 434 ng mL−1 for R-NFLX, 759 ng mL−1 
for S-FLX, and 58 ng mL−1 for R-FLX. 
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fluoxetine and its metabolite, norfluoxetine, by means of 
LC-FD. Among all the evaluated precipitants, acetonitrile 
was the most efficient, considering the necessary number 
of steps and the percentage of protein precipitation (99.7%) 
when it was added at a 3:1 ratio (precipitating agent/ 
plasma, v/v).
According to the analytical validation parameters, the 
PP/LC-FD method is suitable for analysis of antidepressants 
in plasma samples, with good repeatability, inter assay 
precision, limit of quantification, linearity, and selectivity. 
The analysis time (25 min) was satisfactory for quantitative 
analysis.
To evaluate the applicability of the standardized and 
validated method, plasma samples from patients in therapy 
with antidepressants has been reviewed and proven the 
relevance of the technique for the enantioselective analysis 
of fluoxetine and norfluoxetine in plasma samples from 
patients with analyte concentrations between 100 and 
1000 ng mL−1.
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